疑似非ST段抬高急性冠脉综合征患者院内的心脏骤停预测:SAFER评分
基于SWEDEHEART登记库2008–2014年242303例疑似NSTE-ACS患者,用 logistic 回归从26个候选变量中建立SAFER评分:年龄≥60岁(1分)、ST-T异常(2分)、Killip分级>1(1分)、心率<50或≥100次/分(1分)、收缩压<100mmHg(2分)。推导队列c统计量0.72,时间验证队列0.74,外部验证(MINAP)0.65。评分在推导和时间验证中校准尚可但高分倾向高估风险,外部验证总体低估预测风险。该评分有助于入院时识别院内的心脏骤停高危患者。
要点
- SAFER评分含5个入院即可获得的变量:年龄≥60岁(1分)、ST-T异常(2分)、Killip分级>1(1分)、心率<50或≥100次/分(1分)、收缩压<100mmHg(2分)。
- 推导队列(SWEDEHEART 2008–2014,n=242303)c统计量0.72,时间验证队列(n=126073)0.74,外部验证(MINAP,n=276109)0.65。
- 院内的心脏骤停发生率:SWEDEHEART推导队列NSTE-ACS为1.3%、非ACS为0.5%;MINAP为2.3%和2.3%。
- 校准:推导和时间验证队列校准尚可但高分倾向高估风险;外部验证总体低估预测风险。
- 该评分仅用于预测院内的心脏骤停风险,原文未给出基于评分的治疗或监护推荐。
适用人群与场景
- 疑似非ST段抬高急性冠脉综合征(NSTE-ACS)住院患者。
- 推导队列为SWEDEHEART登记库2008–2014年入院患者(n=242303);时间验证队列为SWEDEHEART 2005–2007年患者(n=126073);外部验证队列为MINAP 2008–2013年患者(n=276109)。
诊断标准与关键阈值
- SAFER评分:年龄≥60岁(1分)、ST-T异常(2分)、Killip分级>1(1分)、心率<50或≥100次/分(1分)、收缩压<100mmHg(2分),总分7分。
研究设计与关键结果
- 研究类型:基于登记库的评分推导与验证研究;推导队列n=242303(SWEDEHEART 2008–2014),时间验证队列n=126073(SWEDEHEART 2005–2007),外部验证队列n=276109(MINAP 2008–2013)。
- 从26个候选变量中建立5变量7分SAFER评分。
- 判别力:推导队列c统计量0.72,时间验证队列0.74,外部验证队列0.65。
- 校准:推导和时间验证队列校准尚可,高分时倾向高估风险;外部验证总体低估预测风险。
- 院内的心脏骤停发生率:SWEDEHEART推导队列NSTE-ACS 1.3%、非ACS 0.5%;MINAP NSTE-ACS 2.3%、非ACS 2.3%。
证据类型、等级与局限
- 证据类型:基于登记库的评分推导与验证研究(非RCT)。
- 局限:外部验证判别力中等(c统计量0.65);推导和时间验证队列高分时倾向高估风险,外部验证总体低估预测风险。
对床旁实践的改变
- 对疑似NSTE-ACS住院患者,入院时可用SAFER评分(年龄≥60岁、ST-T异常、Killip分级>1、心率<50或≥100次/分、收缩压<100mmHg)评估院内的心脏骤停风险。
- 原文未根据SAFER评分给出预防院内的心脏骤停的监护或治疗推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To develop a simple risk-score model for predicting in-hospital cardiac arrest (CA) among patients hospitalized with suspected non-ST elevation acute coronary syndrome (NSTE-ACS).
METHODS: Using the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART), we identified patients (n=242 303) admitted with suspected NSTE-ACS between 2008 and 2014. Logistic regression was used to assess the association between 26 candidate variables and in-hospital CA. A risk-score model was developed and validated using a temporal cohort (n=126 073) comprising patients from SWEDEHEART between 2005 and 2007 and an external cohort (n=276 109) comprising patients from the Myocardial Ischaemia National Audit Project (MINAP) between 2008 and 2013.
RESULTS: The incidence of in-hospital CA for NSTE-ACS and non-ACS was lower in the SWEDEHEART-derivation cohort than in MINAP (1.3% and 0.5% vs. 2.3% and 2.3%). A seven point, five variable risk score (age ≥60 years (1 point), ST-T abnormalities (2 points), Killip Class >1 (1 point), heart rate <50 or ≥100bpm (1 point), and systolic blood pressure <100mmHg (2 points) was developed. Model discrimination was good in the derivation cohort (c-statistic 0.72) and temporal validation cohort (c-statistic 0.74), and calibration was reasonable with a tendency towards overestimation of risk with a higher sum of score points. External validation showed moderate discrimination (c-statistic 0.65) and calibration showed a general underestimation of predicted risk.
CONCLUSIONS: A simple points score containing five variables readily available on admission predicts in-hospital CA for patients with suspected NSTE-ACS.
参考来源
- Faxén J, Hall M, Gale CP, et al. A user-friendly risk-score for predicting in-hospital cardiac arrest among patients admitted with suspected non ST-elevation acute coronary syndrome - The SAFER-score. Resuscitation. 2017. PMID: 28993178. doi:10.1016/j.resuscitation.2017.10.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。